Abstract
One-day-old chickens susceptible to Marek's disease were vaccinated with experimental vaccines prepared from purified turkey herpes virus (HVT), inactivated HVT preparations or a membrane fraction isolated from HTV-infected chicken embryo fibroblasts, respectively. Purified HVT was found to be as effective in immunization against Marek's disease as cell-associated virus. The specific mortality of chickens twice vaccinated with cellular membranes from HVT-infected cells was reduced by 94%. These membranes also carried virus-specific antigens as shown by immunodiffusion tests.
From the vaccination and serologic findings one may conclude that the immunologic prevention of Marek's disease by vaccination with the HVT is mediated by antibodies against viral envelope and virus-specific membrane antigens.
Similar content being viewed by others
References
Ahmed, M., Schildlovsky, G.: Detection of virus-associated antigen on membranes of cells productively infected with Marek's disease herpes virus. Cancer Res.32, 187–192 (1972)
Blumenfeld, O. O.: The proteins of the erythrocyte membrane obtained by solubilization with aqueous pyridine solution. Biochem. biophys. Res. Commun.30, 200–205 (1968)
Calnek, B. W.: Immunity and Marek's disease. Vth International Symposium on Comparative Leukemia Research, Padova/Venice, September 13–17, 1971
Chen, J. H., Purchase, H. G.: Surface antigen on chick kidney cells infected with the herpes virus of Marek's disease. Virology40, 410–412 (1970)
Chubb, R. C., Churchill, A. E.: Precipitating antibodies associated with Marek's disease. Vet. Rec.83, 4–7 (1968)
Heine, J. W., Spear, P. G., Roizman, B.: Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane. J. Virol.9, 431–439 (1972)
Hilleman, M. R.: Marek's disease vaccine: its implications in biology and medicine. Avian Dis.16, 191–199 (1972)
Hollinshead, A., McCammon, J. R., Yohn, D. S.: Immunogenicity of a soluble membrane antigen from adenovirus-12 induced tumor-cells demonstrated in inbred hamsters (PD-4). Canad. J. Microbiol.18, 1365–1369 (1972)
Kaaden, O. R., Dietzschold, B.: Some characteristics of a herpes virus of turkeys and its DNA. Proceedings of “Oncogenesis and herpes viruses”, International Agency for Research on Cancer, Lyon, pp. 82–87 (1972)
Lowry, O. M., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurements with the folin phenol reagent. J. biol. Chem.193, 265–275 (1951)
Nazerian, K., Chen, J. H.: Immunoferritin studies of Marek's disease virus directed intracellular and membrane antigens. Arch. ges. Virusforsch.41, 59–65 (1973)
Ne'eman, Z., Kahane, J., Kovartovsky, J., Razin, S.: Characterization of the myoplasma membrane proteins. III. Gel filtration and immunological characterization of Acholeplasma laidlawii membrane proteins. Biochim. biophys. Acta (Amst.)266, 255–268 (1972)
Okazaki, W., Purchase, H. G., Burmester, B. R.: Protection against Marek's disease by vaccination with a herpes virus of turkeys. Avian Dis.14, 413–429 (1970)
Orlans, E., Rose, M. E., Marrack, J. R.: Fowl antibody: I. Some physical and immunochemical properties. Immunology4, 262–277 (1961)
Witter, R. L., Nazerian, K., Purchase, H. G., Burgoyne, G. H.: Isolation from turkeys of a cell-associated herpes virus antigenically related to Marek's disease virus. Amer. J. Vet. Res.31, 525–538 (1970)
Wittmann, G., Bauer, K., Mussgay, M.: Versuche zur Schutzimpfung von Schweinen mit Vakzinen aus inaktiviertem Maul- und Klauenseuche (MKS)-Virus. II. Versuche mit Aethylaethylenimin (EEI)-inaktiviertem Virus und Diaethylaminoaethyl (DEAE)-Dextran als Adjuvans. Arch. ges. Virusforsch.29, 139–158 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaaden, O.R., Dietzschold, B. & UeberschÄr, S. Vaccination against Marek's disease: Immunizing effect of purified turkey herpes virus and cellular membranes from infected cells. Med Microbiol Immunol 159, 261–269 (1974). https://doi.org/10.1007/BF02123735
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02123735